Clinical trials
Phase 3 Acute Coronary Syndrome trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2016 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| DalCor Pharmaceuticals | 1 |
| Sanofi | 1 |
| Takeda | 1 |
| The Hospital District of Satakunta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 9 |
| Coronary Artery Disease | 2 |
| Heart Diseases | 2 |
| Myocardial Infarction | 2 |
| Stroke | 2 |
| Angina, Unstable | 1 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.